Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
NICE has recommended aflibercept (Eylea) as a cost-effective first-line treatment for adults with visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO) within a draft Final Appraisal Determination (FAD).